ESMO National Representative in Germany
|Term||2011 – 2013|
Charite, Campus Benjamin Franklin
Medizinische Klinik III
Dr. Ulrich Keilholz graduated from the University of Heidelberg Medical School in 1983 and trained in Internal Medicine and Haematology/Oncology at the Department of Internal Medicine, University of Heidelberg. Subsequently, he continued to work as attending physician in the same department; however, which included a guest visit to the NIH Surgery branch in 1987. This then laid the basis for the inauguration of the Tumour Immunology Group, which he directed in Heidelberg.
In 1997 he was appointed Professor of Medicine and Vice Chair of the Department of Haematology, Oncology and Transfusion Medicine at the University Hospital Benjamin Franklin, Free University Berlin, (now part of the Charité University Hospital System in Berlin (CBF)). In addition, he Chairs the unit for Interdisciplinary Medical Tumour Therapy of the Charité, CBF. The translational research areas include research in tumour immunology and tumour biology, in addition to his clinical research programme in medical oncology with emphasis on targeted therapies. His current research interest focuses mainly on development of tumour vaccines for a variety of cancer histologies, and on mechanisms of tumour metastasis.
Dr. Ulrich Keilholz is a member of all major international clinical oncology and haematology societies and is very active in the Deutsche Krebsgesellschaft and the European Organization for Research and Treatment of Cancer (EORTC) (early and late phase) clinical trials and translational research projects. He serves on the editorial board of numerous journals, including the Journal of Clinical Oncology and Deutsche Ärzteblatt.